Handbook of Animal Models in Neurological Disorders 2023
DOI: 10.1016/b978-0-323-89833-1.00003-3
|View full text |Cite
|
Sign up to set email alerts
|

Transient occlusion of uterine arteries and intra-amniotic injection of lipopolysaccharide in rats as a model of cerebral palsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 58 publications
0
2
0
Order By: Relevance
“…Indeed, all the known risk factors besides birth prematurity (with ~75% of cerebral palsy patients having been born premature), display rates of cerebral palsy in <15% of all cases (in utero ischemia/infection/inflammation 12%, stroke < 1%, hypoxia-ischemia encephalopathy 15% and asphyxia 2–10%) [ 38 ]. Nonetheless, hypoxia, ischemia, in utero infections and combinations of these have been modelled in rabbits, rats and many other species [ 38 , 315 , 317 ]. Unsurprisingly, due to the low risk-association with cerebral palsy, most of these models do not recapitulate motor dysfunctions [ 38 , 318 ], spasticity or hypertona [ 38 , 318 , 319 ], have an excessive mortality rate or deaths shortly following experiments (unlike the clinical scenario, where mortality in associated with symptom severity) [ 292 , 319 , 320 , 321 ] and lack spasticity [ 38 , 292 , 318 ].…”
Section: Inhibitory Influences On Spastic Cerebral Palsymentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, all the known risk factors besides birth prematurity (with ~75% of cerebral palsy patients having been born premature), display rates of cerebral palsy in <15% of all cases (in utero ischemia/infection/inflammation 12%, stroke < 1%, hypoxia-ischemia encephalopathy 15% and asphyxia 2–10%) [ 38 ]. Nonetheless, hypoxia, ischemia, in utero infections and combinations of these have been modelled in rabbits, rats and many other species [ 38 , 315 , 317 ]. Unsurprisingly, due to the low risk-association with cerebral palsy, most of these models do not recapitulate motor dysfunctions [ 38 , 318 ], spasticity or hypertona [ 38 , 318 , 319 ], have an excessive mortality rate or deaths shortly following experiments (unlike the clinical scenario, where mortality in associated with symptom severity) [ 292 , 319 , 320 , 321 ] and lack spasticity [ 38 , 292 , 318 ].…”
Section: Inhibitory Influences On Spastic Cerebral Palsymentioning
confidence: 99%
“…Unsurprisingly, due to the low risk-association with cerebral palsy, most of these models do not recapitulate motor dysfunctions [ 38 , 318 ], spasticity or hypertona [ 38 , 318 , 319 ], have an excessive mortality rate or deaths shortly following experiments (unlike the clinical scenario, where mortality in associated with symptom severity) [ 292 , 319 , 320 , 321 ] and lack spasticity [ 38 , 292 , 318 ]. One exception to this general lack of suitability is the rat model of transient occlusion of uterine arteries and intra-amniotic injection of lipopolysaccharide [ 317 , 322 ], which despite high experimental mortality [ 317 ], the surviving offspring exhibit locomotor and postural deficits and some indications of spasticity [ 317 ], although there seems to be ventriculomegaly, other white and grey matter lesions and cognitive declines that do not match some aspects of clinical sCP [ 317 ]. Overall, the risk factor models succeed in providing information about the impact of various lesions on brain development but do little to move the needle of sCP translation.…”
Section: Inhibitory Influences On Spastic Cerebral Palsymentioning
confidence: 99%